Terms: = Bone cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Staging
38 results:
1. [A Case of Breast cancer Complicated by Fibrous Dysplasia That Was Difficult to Differentiate from bone Metastasis].
Makino Y; Otani A; Hikino H; Murata Y; Miura H; Harada A
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1465-1467. PubMed ID: 38303309
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic nomograms for breast cancer with lung metastasis: a SEER-based population study.
Xie Y; Lei C; Ma Y; Li Y; Yang M; Zhang Y; Law KN; Wang N; Qu S
BMC Womens Health; 2024 Jan; 24(1):16. PubMed ID: 38172874
[TBL] [Abstract] [Full Text] [Related]
3. The MARECA (national study of management of breast cancer locoregional recurrence and oncological outcomes) study: National practice questionnaire of United Kingdom multi-disciplinary decision making.
Morgan JL; Cheng V; Barry PA; Copson E; Cutress RI; Dave R; Elsberger B; Fairbrother P; Hartup S; Hogan B; Horgan K; Kirwan CC; McIntosh SA; O'Connell RL; Patani N; Potter S; Rattay T; Sheehan L; Wyld L; Kim B;
Eur J Surg Oncol; 2022 Jul; 48(7):1510-1519. PubMed ID: 35410760
[TBL] [Abstract] [Full Text] [Related]
4. The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein.
Lucas LM; Dwivedi V; Senfeld JI; Cullum RL; Mill CP; Piazza JT; Bryant IN; Cook LJ; Miller ST; Lott JH; Kelley CM; Knerr EL; Markham JA; Kaufmann DP; Jacobi MA; Shen J; Riese DJ
Pharmacol Rev; 2022 Jan; 74(1):18-47. PubMed ID: 34987087
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological features and prognosis of male breast cancer.
Wang X; Liu S; Xue Y
J Int Med Res; 2021 Oct; 49(10):3000605211049977. PubMed ID: 34713754
[TBL] [Abstract] [Full Text] [Related]
6. Diagnostic value of
Nguyen A; Fullard K; Sheehan-Dare G; Tang R; Chan L; Ho B; Dear R; Keane J; Hickey A; Nandurkar R; Chen J; Chen A; Lim E; Emmett L
J Med Imaging Radiat Oncol; 2022 Sep; 66(6):731-737. PubMed ID: 34676675
[TBL] [Abstract] [Full Text] [Related]
7. Clinical features of patients with her2-positive breast cancer and development of a nomogram for predicting survival.
Fan Y; Wang Y; He L; Imani S; Wen Q
ESMO Open; 2021 Aug; 6(4):100232. PubMed ID: 34392135
[TBL] [Abstract] [Full Text] [Related]
8. Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis.
Hartkopf AD; Brucker SY; Taran FA; Harbeck N; von Au A; Naume B; Pierga JY; Hoffmann O; Beckmann MW; Rydén L; Fehm T; Aft R; Solà M; Walter V; Rack B; Schuetz F; Borgen E; Ta MH; Bittner AK; Fasching PA; Fernö M; Krawczyk N; Weilbaecher K; Margelí M; Hahn M; Jueckstock J; Domschke C; Bidard FC; Kasimir-Bauer S; Schoenfisch B; Kurt AG; Wallwiener M; Gebauer G; Klein CA; Wallwiener D; Janni W; Pantel K
Eur J Cancer; 2021 Sep; 154():128-137. PubMed ID: 34265505
[TBL] [Abstract] [Full Text] [Related]
9. staging Investigations in Asymptomatic Early Breast cancer Patients at the cancer Centre of Southeastern Ontario.
Kamel D; Youssef V; Hopman WM; Mates M
Curr Oncol; 2021 Jun; 28(3):2190-2198. PubMed ID: 34204717
[TBL] [Abstract] [Full Text] [Related]
10. The Role of Postmastectomy Radiotherapy in Locally Advanced Breast cancer After Pathological Complete Response to Neoadjuvant Chemotherapy.
Flores-Balcázar CH; Castro-Alonso FJ; Hernández-Barragán TP; Delgado-de la Mora J; Daidone A; Trejo-Durán GE
Oncology (Williston Park); 2021 Mar; 35(3):139-143. PubMed ID: 33818049
[TBL] [Abstract] [Full Text] [Related]
11. A Novel staging System for De Novo Metastatic Breast cancer Refines Prognostic Estimates.
Plichta JK; Thomas SM; Sergesketter AR; Greenup RA; Rosenberger LH; Fayanju OM; Kimmick G; Force J; Hyslop T; Hwang ES
Ann Surg; 2022 Apr; 275(4):784-792. PubMed ID: 32657941
[TBL] [Abstract] [Full Text] [Related]
12. Primary Breast Carcinoma of the Vulva Metastatic to Lymph Nodes and bones: A Case Report and Literature Review.
Ananthula A; Lockwood B; Savage J; Malak S; Chen C; Makhoul I; Pennisi A
Perm J; 2020; 24():. PubMed ID: 32097114
[TBL] [Abstract] [Full Text] [Related]
13. Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer.
van Uden DJP; van Maaren MC; Strobbe LJA; Bult P; van der Hoeven JJ; Siesling S; de Wilt JHW; Blanken-Peeters CFJM
Breast Cancer Res; 2019 Oct; 21(1):113. PubMed ID: 31623649
[TBL] [Abstract] [Full Text] [Related]
14. Overuse of Preoperative staging of Patients Undergoing Neoadjuvant Chemotherapy for Breast cancer.
Srour MK; Lee M; Walcott-Sapp S; Luu M; Chung A; Giuliano AE; Amersi F
Ann Surg Oncol; 2019 Oct; 26(10):3289-3294. PubMed ID: 31342365
[TBL] [Abstract] [Full Text] [Related]
15. Identification of MiR-125a as a Novel Plasma Diagnostic Biomarker for Chronic Lymphoblastic Leukemia.
Ahmadvand M; Eskandari M; Khakpour G; Pashaiefar H; Manoochehrabadi S; Yaghmaie M; Montazer-Zohour M; Naghavi A
Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868841
[No Abstract] [Full Text] [Related]
16. Population-based validation of the National cancer Comprehensive Network recommendations for breast cancer staging.
Abdel-Rahman O
Breast Cancer Res Treat; 2018 Nov; 172(1):231-238. PubMed ID: 30022329
[TBL] [Abstract] [Full Text] [Related]
17. RNA Profiles of Circulating Tumor Cells and Extracellular Vesicles for Therapy Stratification of Metastatic Breast cancer Patients.
Keup C; Mach P; Aktas B; Tewes M; Kolberg HC; Hauch S; Sprenger-Haussels M; Kimmig R; Kasimir-Bauer S
Clin Chem; 2018 Jul; 64(7):1054-1062. PubMed ID: 29769179
[TBL] [Abstract] [Full Text] [Related]
18. New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes.
Buonomo OC; Caredda E; Portarena I; Vanni G; Orlandi A; Bagni C; Petrella G; Palombi L; Orsaria P
PLoS One; 2017; 12(9):e0184680. PubMed ID: 28922402
[TBL] [Abstract] [Full Text] [Related]
19. Use and Yield of Baseline Imaging and Laboratory Testing in Stage II Breast cancer.
Bychkovsky BL; Guo H; Sutton J; Spring L; Faig J; Dagogo-Jack I; Battelli C; Houlihan MJ; Yeh TC; Come SE; Lin NU
Oncologist; 2016 Dec; 21(12):1495-1501. PubMed ID: 27551013
[TBL] [Abstract] [Full Text] [Related]
20. Gastrin-releasing Peptide Receptor Imaging in Breast cancer Using the Receptor Antagonist (68)Ga-RM2 And PET.
Stoykow C; Erbes T; Maecke HR; Bulla S; Bartholomä M; Mayer S; Drendel V; Bronsert P; Werner M; Gitsch G; Weber WA; Stickeler E; Meyer PT
Theranostics; 2016; 6(10):1641-50. PubMed ID: 27446498
[TBL] [Abstract] [Full Text] [Related]
[Next]
